Few Individuals With Mental, Substance Use Disorders Receive Guideline-Consistent Treatment
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 14, 2025 -- A small number of individuals with mental and substance use disorders receive guideline-consistent treatment worldwide, according to a study published online Feb. 5 in JAMA Psychiatry.
Daniel V. Vigo, M.D., Dr.P.H., from the University of British Columbia in Vancouver, Canada, and colleagues examined the proportion of mental and substance use disorders receiving guideline-consistent treatment in multiple countries. The analysis included 56,927 respondents from World Mental Health surveys (2001 to 2019).
The researchers found that the proportion of 12-month person-disorders receiving effective treatment was 6.9 percent. Major barriers included low perceived need (46.5 percent), low treatment contact given perceived need (34.1 percent), and low effective treatment given minimally adequate treatment (47.0 percent), with substantial variation across disorders. Country-level general medical treatment resources were more important than mental health treatment resources in predicting guideline-consistent treatment. Significant predictors were largely mediated by treatment contact.
"These results highlight the importance of increasing perceived need, the largest barrier to effective treatment; training primary care clinicians in recognition and treatment of mental disorders; and improving the quality of care, especially from minimally adequate to effective treatment," the authors write.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-15 06:00
Read more
![](https://drugslib.com/public/donate.png)
- Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
- ART Pregnancies Have Higher Exposure to Teratogenic Medications
- Rapid Blood Test Can Improve Stroke Treatment
- New Bird Flu Strain Detected in the U.S.
- Fresh Better Than Frozen For IVF
- What Cancer Screenings Do You Need? A Quick Guide
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions